Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Drug Safety
Metadata
Title
A Risk-Benefit Assessment of Metformin in Type 2 Diabetes Mellitus
Authors
Dr Harry C. S. Howlett
Clifford J. Bailey
Publication date
01-06-1999
Publisher
Springer International Publishing
Published in
Drug Safety / Issue 6/1999
Print ISSN: 0114-5916
Electronic ISSN: 1179-1942
DOI
https://doi.org/10.2165/00002018-199920060-00003

Other articles of this Issue 6/1999

Drug Safety 6/1999 Go to the issue

Review Article

Adverse Skin Reactions to Low Molecular Weight Heparins

Current Opinion

Is There an Increased Risk of Stroke Associated with Oral Contraceptives?

Leading Article

Lymphoma in Patients with Rheumatoid Arthritis

Practical Drug Safety

Prophylaxis and Treatment of NSAID-Induced Gastroduodenal Disorders

Review Article

A Preliminary Risk-Benefit Assessment of Latanoprost and Unoprostone in Open-Angle Glaucoma and Ocular Hypertension

Original Research Article

Predictors and Timing of Adverse Experiences During Transdermal Nicotine Therapy